论文信息 - First in human phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of KU-0059436 (Ku), a small molecule inhibitor of poly ADP-ribose polymerase (PARP) in cancer patients (p), including BRCA1/2 mutation carriers - 字舞流文

First in human phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of KU-0059436 (Ku), a small molecule inhibitor of poly ADP-ribose polymerase (PARP) in cancer patients (p), including BRCA1/2 mutation carriers

A. Tutt | J. Carmichael | J. Schellens | M. O’Connor | S. Kaye | T. Yap | D. Boss | J. Schellens | J. Bono | P. Fong | J. Carmichael | M. Roelvink